文拉法辛治疗宫颈癌患者抑郁症的疗效研究
Effect of venlafaxine on cervical cancer patients with depressive symptoms
胡敏优 1姜义彬 1金娇杨 2张卫华1
作者信息
- 1. 317200,浙江省台州,台州市第二人民医院精神科
- 2. 浙江省天台人民医院普内科
- 折叠
摘要
目的 探讨文拉法辛改善宫颈癌患者抑郁、焦虑症状的疗效及安全性,并全面评价患者用药前后的生活质量.方法 对63例宫颈癌抑郁症患者进行8周的文拉法辛治疗,采用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、不良反应量表(TESS)和相关实验室检查评价文拉法辛对宫颈癌抑郁症患者抑郁、焦虑的疗效以及安全性,采用世界卫生组织生存质量评定量表(WHOQOL)评价患者用药前后的生活质量.结果:治疗后患者焦虑、抑郁情绪比入组时明显降低(P＜0.01),有效率分别为65%和52%;患者用药期间未出现明显药物不良反应;患者生活质量中的生理、心理、独立性三个领域有明显改善.结论 文拉法辛能明显改善宫颈癌患者的抑郁、焦虑症状,起效时间为2～4周,不良反应较少;应用文拉法辛治疗患者抑郁症状的同时能明显提高患者的生活质量.
Abstract
Objective To study the effect and reliability of venlafaxine on depression and anxiety symptoms in cervical cancer patient,and to assess the overall quality of life before and after treatment.Methods We treated 63 cervical cancer patients with depression by use of venlafaxine for 8 weeks,at the same time,evaluated their emotion state.change of quality of life and the adverse effect with HAMD,HAMA,TESS and laboratory tests.Results After 8 weeks.patients' scores of anxiety and depression decreased significantly from the baseline(P＜0.01),effective rates were 65%and 52%respectively.Three domains of quality of life(physiology,psychology and independence)became much better than those of baseline(P＜0.05).Conclusions This studyshows that venlafaxine can reduce the depression and anxiety symptoms in cervical cancer patients,and the react time is 2 to 4 weeks.Venlafaxine with the treatment of depression and enxiety can improve the quality 0f patients' life.
关键词
宫颈肿瘤/抑郁症/抗抑郁药/文拉法辛Key words
Cervical neoplasms/Depression/Antidepressive agents/Venlafaxine引用本文复制引用
出版年
2008
NETL
NSTL
维普
万方数据